Fig 2: Prognostic riskscores correlated with stage, immunescore, and clinicopathological parameters in cervical cancer. (A) Heatmap and clinicopathologic parameters of high- and low-risk groups. (B–D) The differences of METTL16, YTHDF1, and ZC3H13 expression in low- and high-risk groups. (E) The relationship between riskscore and PD-L1 expression *p < 0.05; ****p < 0.0001.

Fig 3: IHC was performed to measure the expression of PD-L1, METTL16, YTHDF1, and ZC3H13 in cervical cancer tissues and surrounding normal tissues.